- Home
- OWL vs MEDP Comparison
OWL vs MEDP Comparison
Compare OWL & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OWL
- MEDP
- Stock Information
- Founded
- OWL 2020
- MEDP 1992
- Country
- OWL United States
- MEDP United States
- Employees
- OWL N/A
- MEDP N/A
- Industry
- OWL Investment Managers
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- OWL Finance
- MEDP Health Care
- Exchange
- OWL Nasdaq
- MEDP Nasdaq
- Market Cap
- OWL 10.6B
- MEDP 13.4B
- IPO Year
- OWL N/A
- MEDP 2016
- Fundamental
- Price
- OWL $15.21
- MEDP $596.03
- Analyst Decision
- OWL Buy
- MEDP Hold
- Analyst Count
- OWL 15
- MEDP 11
- Target Price
- OWL $22.50
- MEDP $451.70
- AVG Volume (30 Days)
- OWL 14.8M
- MEDP 339.4K
- Earning Date
- OWL 10-30-2025
- MEDP 10-22-2025
- Dividend Yield
- OWL 6.04%
- MEDP N/A
- EPS Growth
- OWL 47.85
- MEDP 25.36
- EPS
- OWL 0.08
- MEDP 14.32
- Revenue
- OWL $2,745,943,000.00
- MEDP $2,358,373,000.00
- Revenue This Year
- OWL $17.06
- MEDP $21.48
- Revenue Next Year
- OWL $21.21
- MEDP $11.90
- P/E Ratio
- OWL $192.30
- MEDP $41.92
- Revenue Growth
- OWL 27.24
- MEDP 13.88
- 52 Week Low
- OWL $14.52
- MEDP $250.05
- 52 Week High
- OWL $26.73
- MEDP $625.00
- Technical
- Relative Strength Index (RSI)
- OWL 41.12
- MEDP 65.47
- Support Level
- OWL $14.52
- MEDP $573.07
- Resistance Level
- OWL $16.34
- MEDP $602.54
- Average True Range (ATR)
- OWL 0.69
- MEDP 20.36
- MACD
- OWL -0.08
- MEDP -1.03
- Stochastic Oscillator
- OWL 26.38
- MEDP 48.82
About OWL Blue Owl Capital Inc.
Blue Owl Capital Inc is an alternative asset management firm. The company deploys private capital across Credit, GP Strategic Capital, and Real Estate platforms on behalf of institutional and private wealth clients. The company conducts its operations through Blue Owl Capital Holdings LP (Blue Owl Holdings) and Blue Owl Capital Carry LP (Blue Owl Carry). Its investor base includes a diversified mix of institutional investors, including public and private pension funds, endowments, foundations, family offices, private banks, high-net-worth individuals, asset managers, and insurance companies. The company generates substantially all of its revenues in the United States.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.